Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Corgentech Appoints Patrick Broderick as General Counsel and Corporate Secretary
Jul 13, 2004
|
69.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jul 13, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, announced today that Patrick Broderick has joined the Company as vice president, general counsel and corporate secretary. He will be responsible for overseeing all aspects of the Company's legal affairs.
Pri...
|
|
|
Corgentech Appoints Thomas J. Colligan to Board of Directors
Jun 29, 2004
|
69.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jun 29, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, announced today that Thomas J. Colligan, retired vice chairman of PricewaterhouseCoopers, has been appointed to the Company's board of directors effective July 1, 2004.
"We are fortunate to have an individual...
|
|
|
Corgentech Announces Phase III CABG Trial (Prevent IV) Proceeding as Planned
Jun 24, 2004
|
69.4 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jun 24, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today announced that the Steering Committee responsible for the oversight of its Phase III trial evaluating edifoligide (E2F Decoy) for the prevention of coronary artery bypass graft (CABG) failure advised that the trial could continue as...
|
|
|
Corgentech to Present at Needham Third Annual Biotechnology Conference
Jun 10, 2004
|
66.9 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jun 10, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that Richard P. Powers, the company's vice president and chief financial officer, will present at the Needham Third Annual Biotechnology Conference on Wednesday June 16, 2004 at 2:00 p.m. EDT at t...
|
|
|
Corgentech to Present at UBS 2004 Global Specialty Pharmaceuticals Conference
May 21, 2004
|
68.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., May 21, 2004 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John McLaughlin, the company's president and chief executive officer, will present at the UBS 2004 Global Specialty Pharmaceuticals Conference on Tuesday, May 25, 2004 at 4:30 p.m. EDT at the...
|
|
|
Click here to download our most recent fact sheet.